TY - JOUR
T1 - Correction to
T2 - Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers (Cancers, (2020), 12, 8, (2209), 10.3390/cancers12082209)
AU - Soung, Young Hwa
AU - Chung, Heesung
AU - Yan, Cecilia
AU - Fesler, Andrew
AU - Kim, Hyungjin
AU - Oh, Eok Soo
AU - Ju, Jingfang
AU - Chung, Jun
N1 - Publisher Copyright:
© 2024 by the authors.
PY - 2024/3
Y1 - 2024/3
N2 - In the original publication [1], there was a mistake in Figure 4C and the Supplementary Materials as published. GAPDH blot in Figure 3B was used in GAPDH blot in Figure 4C by mistake. We realized that the GAPDH band for Figure 4C was incorrectly labeled as β-actin in Figure S3. We herein replace the erroneous figure with the correct one. For the Supplementary Materials, we add the full pictures of the Western blots in Figure S3. The corrected GAPDH of Figure 4C and the description of the Supplementary Materials appear below. The authors apologize for any inconvenience caused and state that the scientific conclusions remain unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Delivery of 5-FU-miR-489 mimic (CMM489) does not require a transfection reagent. miR-negative control (NC), miR-489 and CMM489 were transfected into MDA-MB-231 cells (A) or HCC-1937 cells (B) with or without oligofectamine reagent. The density of cells was imaged at 6 days by phase contrast microscopy. Representative images were selected from three independent experiments. Scale bar: 100 μm. The cell numbers were counted using Trypan blue staining and a hematocytometer. Column, mean from three independent experiments; bars, SD. * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Whole cell lysate from MDA-MB-231 cells transfected with the indicated miRNAs without oligofectamine reagent were analyzed by Western blot assay with antibodies against MDC1, SUZ12, TS-FdUMP and β-actin. Densitometric analysis was performed using Image J. Representative images were carried out at least 3 times. Supplementary Materials: The following supporting information can be downloaded at: https://www.mdpi.com/2072-6694/12/8/2209/s1, Figure S1: miR-489 mediates anti-proliferative role in TNBC cells; Figure S2: The levels of miR-489 in transfected cells; Figure S3: Full pictures of the Western blots.
AB - In the original publication [1], there was a mistake in Figure 4C and the Supplementary Materials as published. GAPDH blot in Figure 3B was used in GAPDH blot in Figure 4C by mistake. We realized that the GAPDH band for Figure 4C was incorrectly labeled as β-actin in Figure S3. We herein replace the erroneous figure with the correct one. For the Supplementary Materials, we add the full pictures of the Western blots in Figure S3. The corrected GAPDH of Figure 4C and the description of the Supplementary Materials appear below. The authors apologize for any inconvenience caused and state that the scientific conclusions remain unaffected. This correction was approved by the Academic Editor. The original publication has also been updated. Delivery of 5-FU-miR-489 mimic (CMM489) does not require a transfection reagent. miR-negative control (NC), miR-489 and CMM489 were transfected into MDA-MB-231 cells (A) or HCC-1937 cells (B) with or without oligofectamine reagent. The density of cells was imaged at 6 days by phase contrast microscopy. Representative images were selected from three independent experiments. Scale bar: 100 μm. The cell numbers were counted using Trypan blue staining and a hematocytometer. Column, mean from three independent experiments; bars, SD. * p < 0.05, ** p < 0.01, *** p < 0.001. (C) Whole cell lysate from MDA-MB-231 cells transfected with the indicated miRNAs without oligofectamine reagent were analyzed by Western blot assay with antibodies against MDC1, SUZ12, TS-FdUMP and β-actin. Densitometric analysis was performed using Image J. Representative images were carried out at least 3 times. Supplementary Materials: The following supporting information can be downloaded at: https://www.mdpi.com/2072-6694/12/8/2209/s1, Figure S1: miR-489 mediates anti-proliferative role in TNBC cells; Figure S2: The levels of miR-489 in transfected cells; Figure S3: Full pictures of the Western blots.
UR - http://www.scopus.com/inward/record.url?scp=85187715402&partnerID=8YFLogxK
U2 - 10.3390/cancers16051010
DO - 10.3390/cancers16051010
M3 - Comment/debate
AN - SCOPUS:85187715402
SN - 2072-6694
VL - 16
JO - Cancers
JF - Cancers
IS - 5
M1 - 1010
ER -